Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.177 (
BIS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Valence modulation and prepulse inhibition of startle were examined among 80 undergraduates scoring in the upper and lower quartiles of self-report measures of behavioral inhibition (
BIS
) and behavioral approach (BAS). Participants viewed a series of pleasant, neutral, and unpleasant pictures. Acoustic startle probes (102 dB) were presented during most pictures and during intertrial intervals, and a prepulse (120-ms
SOA
) preceded half of the probes. Valence modulation on no-prepulse trials was greater among high-BAS than low-BAS participants. Consistent with theory regarding behavioral approach, post hoc tests demonstrated robust inhibition during pleasant versus neutral pictures among high-BAS participants, but not low-BAS participants. Valence modulation was reliable among high-
BIS
but not low-
BIS
participants, but the group difference was not significant. Contrary to our prediction, prepulse inhibition tended to be greater among high-BAS than low-BAS participants. The present data call attention to the role of individual differences in pleasant affective experience in startle modification.
...
PMID:Affective modulation and prepulse inhibition of startle among undergraduates high and low in behavioral inhibition and approach. 1275 10